Prolapse Symptoms Versus Prolapse Stage: Why the Two Diverge

Prolapse defined by symptoms has a prevalence of about 3% to 6% of women, while prolapse defined by vaginal examination reaches up to 50%, and those two figures are answers to two different questions rather than a contradiction. Stage records where tissue sits during an examination. Symptoms record what a whole day of standing, lifting and being tired produces. Treatment is aimed at the second¹.

I do not have a prolapse and I am not going to write as though I do. What I have is a waiting room’s worth of overheard conversations from sixteen weeks of appointments, and the sentence I heard most often from the women sitting next to me was some version of “they told me it was only a small one”. That sentence is the reason this node exists as its own article, because “small” is a statement about an examination and the symptom is a statement about a day. Read red flags and when to stop and get checked first: a painful, discoloured or irreducible prolapse needs a clinician the same day.

What a stage actually records

A position, measured against a fixed landmark, at one moment.

POP-Q is a standardised system that describes how far the vaginal walls, the uterus or, after hysterectomy, the vaginal vault descend relative to the hymen when you strain, and summarises the result as a stage from 0 to 4. It is careful, reproducible and genuinely useful for comparing one examination with another. The International Urogynecological Association publishes plain-language material explaining the compartments and the vocabulary for patients who have received a letter full of it².

Note the conditions attached. It is measured on a couch, usually earlier in the day rather than later, during a deliberate effort, in a clinical setting. The symptom is produced by eight hours of gravity, whatever you carried, whether you strained on the toilet, and how tired you are by four o’clock. Those are not the same experiment.

The four numbers that show the divergence

Put them side by side and the gap is obvious.

• By symptoms: about 3% to 6%. Produced for the Fifth International Consultation on Incontinence¹.
• By self-report in a national sample: 2.9%. In 1,961 non-pregnant US women aged 20 and over, with a 95% confidence interval of 2.1 to 3.7, defined as seeing or feeling a bulge in or outside the vagina³.
• By vaginal examination: up to 50%¹. NICE records the same split in UK primary care: 8.4% of women reported a vaginal bulge or lump, while on examination prolapse is present in up to 50% of women⁴.
• In a routine gynaecology clinic population: 76% at stage 1 or above. In 1,004 women aged 18 to 83 attending routine outpatient gynaecology appointments, the POP-Q distribution was 24% stage 0, 38% stage 1, 35% stage 2 and 2% stage 3⁵.

That last one is worth sitting with. In an ordinary clinic population, more than three quarters of women had a measurable degree of descent, and 35% were at stage 2, which is the stage most often described to a woman as “a small prolapse”. Most of those women were not there about prolapse.

After the menopause the anatomical figures rise further. Among 16,616 women aged 50 to 79 with a uterus who had a baseline pelvic examination in the Women’s Health Initiative, uterine prolapse was found in 14.2%, cystocele in 34.3% and rectocele in 18.6%⁶. Menopause and the pelvic floor covers what changes and what it means.

Why this is the mechanism of a dismissal

Because a sourced figure can be used to make a real symptom sound universal.

If a woman with a troubling bulge is told that half of women have this, the statement is technically supported and completely misleading. She is not in the up-to-50% group who have measurable descent on examination; she is in the 3% to 6% group who are troubled by it. Quoting the examination figure to answer a question about symptoms substitutes one denominator for another, and it is the single most common way a treatable pelvic problem gets closed down in a consultation.

The reverse error also happens. A woman with stage 2 and no symptoms can be alarmed into treatment she does not need by being handed a number as though it were a diagnosis. Both errors come from the same source: treating stage as a proxy for trouble.

Why symptoms get dismissed and how to be heard covers the general version of this move, including how to reframe the question so it has a checkable answer.

What the trials measured, which tells you what matters

The largest and most recent trial of conservative treatment did not use stage as its primary outcome, and that is not an accident.

The POPPY trial randomised 447 women with newly diagnosed symptomatic stage I, II or III prolapse across 25 centres in three countries, 225 to individualised pelvic floor muscle training and 222 to a control group who received a prolapse lifestyle advice leaflet and no muscle training. The primary outcome was self-reported prolapse symptoms at 12 months on the Pelvic Organ Prolapse Symptom Score, which runs from 0 to 28. The training group improved by a mean of 3.77 points against 2.09 in controls, an adjusted difference of 1.52, 95% confidence interval 0.46 to 2.59, p = 0.0053⁷.

Two things travel with that. It is a 1.52 point difference on a 28 point scale, which is good evidence of direction and modest evidence of magnitude. And follow-up was 377 women, 84%, at 6 months but only 295, 66%, at 12 months, which is substantial attrition for a primary outcome.

You will also find a percentage quoted for POPPY: the proportion in each arm who said their prolapse symptoms were better. Figures such as 57% against 45% circulate online. They are not in the published abstract, and this site does not publish a number it has not read in the paper. If you see one, ask where it came from.

For the anatomical question, the honest position is thinner. A 2011 Cochrane review reported that pooled data from two trials indicated pelvic floor muscle training increases the chance of an improvement in prolapse stage by 17% compared with no training, and concluded there is some evidence of a positive effect on prolapse symptoms and severity⁸. That review is from 2011, predates POPPY entirely, and citing it as the current Cochrane evidence is technically true and substantively misleading. The same review contains a prolapse symptom score mean difference that this site does not quote, because it could not be re-confirmed against the source table.

So what is stage for

Defining a population, mostly, and providing a baseline.

NICE NG123 recommendation 1.7.5 says to consider a programme of supervised pelvic floor muscle training for at least 16 weeks as a first option for women with symptomatic POP-Q stage 1 or stage 2 prolapse⁴. NG210 recommendation 1.6.13 expresses the same recommendation anatomically rather than by stage: consider a supervised programme for at least 4 months for women with symptomatic prolapse that does not extend more than 1 cm beyond the hymen on straining⁹.

Three precision points, because most summaries get one of them wrong. The verb is consider rather than offer, which is weaker than the recommendation for stress incontinence. The duration is 16 weeks or 4 months, not the three months people import from the incontinence recommendation. And the two durations are not a disagreement: NG210’s own rationale explains that 16 weeks for prolapse and 3 months for urinary incontinence were the most common points at which trials assessed their results.

Notice the word that appears in both: symptomatic. Stage defines which symptomatic women the recommendation applies to. It does not by itself put anybody into treatment.

What to measure instead

Whatever you actually want back.

The useful markers are functional and personal: heaviness at four o’clock, whether you can carry shopping up a flight of stairs, whether you finish a run, whether emptying feels complete, and what you have stopped doing. A symptom score gives you a number to compare at a review; a function list gives you the thing the number is standing in for.

The one sentence from my own course that transfers directly is from my six week review. My physiotherapist did not open by telling me a muscle was stronger. She asked what I could do in May that I could not do in March. I found it irritating at the time and entirely right afterwards, and it is exactly the logic that should govern a prolapse programme. Questions to ask at your first appointment covers how to get progress measurement agreed at the start rather than improvised at the end.

Where this leaves the treatment decision

With symptoms in charge and stage as context.

Pelvic organ prolapse sets out what conservative treatment achieves and what it does not, pelvic floor exercise programmes explained covers how a programme is built and progressed, and vaginal pessaries alongside physiotherapy covers the conservative option that sits beside training rather than after it. Bowel management belongs in the same conversation, because straining is a daily load on the same structures: see constipation and obstructed defaecation.

On surgery, NICE says to offer it to women whose symptoms have not improved with non-surgical treatment or who have declined non-surgical treatment⁴, so an informed refusal is a legitimate route and nobody has to prove they suffered adequately first. NICE also records that about 1 in 10 women will need at least 1 surgical procedure, with a re-operation rate as high as 19%. When physiotherapy is not enough covers what a fair trial looks like and what the next conversation contains, and pelvic floor physiotherapy sets the whole treatment out.